ICM
CRMD icon

Ionic Capital Management’s CorMedix CRMD Stock Holding History

Ionic Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,000
Closed -$98K – 280
2015
Q1 		$98K Buy
+2,000
New +$47.4K ﹤0.01% 255

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ionic Capital Management's CRMD Position: Q2 2015 in Review

Ionic Capital Management sold out of CorMedix (CRMD) in Q2 2015, closing a stake of 1,864 shares — an estimated $92K sold.

Ionic Capital Management first reported a position in CRMD in Q1 2015 and held it in 1 quarter. The position peaked at $92K in Q1 2015. 57 funds tracked by Wall St. Rank hold CRMD as of Q2 2015.

  • Ionic Capital Management reported no remaining CorMedix position as of Q2 2015 after selling out during the quarter.
  • Ionic Capital Management sold 1,864 CorMedix shares in Q2 2015, an estimated $92K.
  • Ionic Capital Management first reported a position in CorMedix in Q1 2015 and held it in 1 quarter.
  • Ionic Capital Management's CorMedix position peaked at $92K in Q1 2015.
  • 57 funds tracked by Wall St. Rank held CorMedix as of Q2 2015.

Based on Ionic Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.